Skip to main content
. 2022 Jul 25;62(15):3664–3675. doi: 10.1021/acs.jcim.2c00417

Table 1. Systems for MD Simulations.

system total simulation time agonist
FFAR1-(R)-AM-8596 3 μs (1 μs per simulation) (R)-AM-8596
FFAR1-(S)-AM-8596 3 μs (1 μs per simulation) (S)-AM-8596
FFAR1-γ-linolenic-acid 3 μs (1 μs per simulation) γ-linolenic acid
FFAR1-apo 3 μs (1 μs per simulation)